Sera Prognostics (SERA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.06, +1.48% vs the prior close of $2.03.
- Volume 3.53K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SERA rises 1.5% to $2.06. Closed at $2.06, +1.48% vs the prior close of $2.03. Day range $2.03–$2.06, opened at $2.03.
SERA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SERA rises 1.5% to $2.06
- Closed at $2.06, +1.48% vs the prior close of $2.03. Day range $2.03–$2.06, opened at $2.03.
- Volume was 3.53K shares, 0.2x its 50-day average of 21.05K — lighter than usual.
- Price is +0.6% vs its 50-day average ($2.05) and -6.1% vs its 200-day average ($2.19).
- 52-week range $1.56–$3.95; today's close sits at 21% of that range, 47.8% below the 52-week high.
Oct 15, 2026 — SERA dips 1.9% to $2.03
- Closed at $2.03, -1.93% vs the prior close of $2.07. Day range $2.03–$2.09, opened at $2.07.
- Volume was 13.30K shares, 0.6x its 50-day average of 21.95K.
- Price is -0.8% vs its 50-day average ($2.05) and -7.7% vs its 200-day average ($2.20).
- 52-week range $1.56–$3.95; today's close sits at 20% of that range, 48.6% below the 52-week high.
Oct 14, 2026 — SERA rises 1.5% to $2.07
- Closed at $2.07, +1.47% vs the prior close of $2.04. Day range $2.03–$2.07, opened at $2.03.
- Volume was 5.80K shares, 0.2x its 50-day average of 23.58K — lighter than usual.
- Price is +1.2% vs its 50-day average ($2.05) and -6.1% vs its 200-day average ($2.21).
- 52-week range $1.56–$3.95; today's close sits at 21% of that range, 47.6% below the 52-week high.
Oct 13, 2026 — SERA dips 1.4% to $2.04
- Closed at $2.04, -1.45% vs the prior close of $2.07. Day range $2.03–$2.05, opened at $2.04.
- Volume was 4.70K shares, 0.2x its 50-day average of 23.79K — lighter than usual.
- Price is -0.1% vs its 50-day average ($2.04) and -7.8% vs its 200-day average ($2.21).
- 52-week range $1.56–$3.95; today's close sits at 20% of that range, 48.4% below the 52-week high.
Oct 12, 2026 — SERA rises 1.5% to $2.07
- Closed at $2.07, +1.47% vs the prior close of $2.04. Day range $2.03–$2.10, opened at $2.06.
- Volume was 13.80K shares, 0.6x its 50-day average of 24.01K — lighter than usual.
- Price is +1.3% vs its 50-day average ($2.04) and -6.8% vs its 200-day average ($2.22).
- 52-week range $1.56–$3.95; today's close sits at 21% of that range, 47.6% below the 52-week high.
Oct 9, 2026 — SERA rises 1.0% to $2.04
- Closed at $2.04, +0.99% vs the prior close of $2.02. Day range $2.01–$2.10, opened at $2.01.
- Volume was 6.30K shares, 0.2x its 50-day average of 25.46K — lighter than usual.
- Price is -0.1% vs its 50-day average ($2.04) and -8.4% vs its 200-day average ($2.23).
- 52-week range $1.56–$3.95; today's close sits at 20% of that range, 48.4% below the 52-week high.
Oct 8, 2026 — SERA dips 2.4% to $2.02
- Closed at $2.02, -2.42% vs the prior close of $2.07. Day range $2.01–$2.21, opened at $2.21.
- Volume was 13.40K shares, 0.5x its 50-day average of 25.42K — lighter than usual.
- Price is -1.2% vs its 50-day average ($2.04) and -9.6% vs its 200-day average ($2.24).
- 52-week range $1.56–$3.95; today's close sits at 19% of that range, 48.9% below the 52-week high.
Oct 7, 2026 — SERA rises 1.0% to $2.07
- Closed at $2.07, +0.98% vs the prior close of $2.05. Day range $2.01–$2.07, opened at $2.01.
- Volume was 800 shares, 0.0x its 50-day average of 25.92K — lighter than usual.
- Price is +1.2% vs its 50-day average ($2.04) and -7.7% vs its 200-day average ($2.24).
- 52-week range $1.56–$3.95; today's close sits at 21% of that range, 47.6% below the 52-week high.
Oct 6, 2026 — SERA rises 2.5% to $2.05
- Closed at $2.05, +2.50% vs the prior close of $2.00. Day range $2.02–$2.12, opened at $2.12.
- Volume was 4.40K shares, 0.2x its 50-day average of 27.37K — lighter than usual.
- Price is +0.3% vs its 50-day average ($2.04) and -8.9% vs its 200-day average ($2.25).
- 52-week range $1.56–$3.95; today's close sits at 21% of that range, 48.1% below the 52-week high.
Oct 5, 2026 — SERA slides 4.3% to $2.00
- Closed at $2.00, -4.31% vs the prior close of $2.09. Day range $2.00–$2.15, opened at $2.08.
- Volume was 22.90K shares, 0.8x its 50-day average of 27.29K.
- Price is -2.1% vs its 50-day average ($2.04) and -11.4% vs its 200-day average ($2.26).
- 52-week range $1.56–$3.95; today's close sits at 18% of that range, 49.4% below the 52-week high.
Oct 2, 2026 — SERA rises 2.5% to $2.09
- Closed at $2.09, +2.45% vs the prior close of $2.04. Day range $2.04–$2.15, opened at $2.04.
- Volume was 21.90K shares, 0.8x its 50-day average of 27.27K.
- Price is +2.2% vs its 50-day average ($2.04) and -7.8% vs its 200-day average ($2.27).
- 52-week range $1.56–$3.95; today's close sits at 22% of that range, 47.1% below the 52-week high.
SERA latest news & SEC filings
Every SEC filing by or about SERA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Inglis Tiffany Eul Davis sold 8,024 shares at $2.03 (≈$16.29K) on Oct 12, 2026; now holds 83,565
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Anderson Dyaarl Lee Jr. sold 1,800 shares at $2.00 (≈$3.60K) on Sep 10, 2026
- Anderson Dyaarl Lee Jr. sold 1,800 shares at $2.00 (≈$3.60K) on Sep 10, 2026
- Anderson Dyaarl Lee Jr. sold 1,800 shares at $2.00 (≈$3.60K) on Sep 10, 2026
- Anderson Dyaarl Lee Jr. sold 1,800 shares at $2.00 (≈$3.60K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lindgardt Zhenya sold 7,022 shares at $2.00 (≈$14.04K) on Sep 10, 2026
- Lindgardt Zhenya sold 7,022 shares at $2.00 (≈$14.04K) on Sep 10, 2026
- Lindgardt Zhenya sold 7,022 shares at $2.00 (≈$14.04K) on Sep 10, 2026
- Lindgardt Zhenya sold 7,022 shares at $2.00 (≈$14.04K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Inglis Tiffany Eul Davis sold 486 shares at $2.00 (≈$972) on Sep 10, 2026
- Inglis Tiffany Eul Davis sold 486 shares at $2.00 (≈$972) on Sep 10, 2026
- Inglis Tiffany Eul Davis sold 486 shares at $2.00 (≈$972) on Sep 10, 2026
- Inglis Tiffany Eul Davis sold 486 shares at $2.00 (≈$972) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jackson Benjamin sold 2,190 shares at $2.00 (≈$4.38K) on Sep 10, 2026
- Jackson Benjamin sold 2,190 shares at $2.00 (≈$4.38K) on Sep 10, 2026
- Jackson Benjamin sold 2,190 shares at $2.00 (≈$4.38K) on Sep 10, 2026
- Jackson Benjamin sold 2,190 shares at $2.00 (≈$4.38K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $30.00K (prior year $17.00K) (+76.5% vs Jun 30, 2025)
- Net income: -$9.14M (prior year -$8.05M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.18 (prior year -$0.16) (loss widened vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 15, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade SERA
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 18, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.02% (largest 4.3%).
- Liquidity: about 9.99K shares (≈$20.57K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.06 vs a range of $1.56–$3.95 (21% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Tiffany Eul Davis Inglis sold 486 shares on Sep 10, 2026.
- Latest filings: 8-K Aug 19, 2026; 10-Q Aug 12, 2026; 8-K Aug 12, 2026.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
SERA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.03 | 2.06 | 2.03 | 2.06 | 3.53K |
| Oct 15, 2026 | 2.07 | 2.09 | 2.03 | 2.03 | 13.30K |
| Oct 14, 2026 | 2.03 | 2.07 | 2.03 | 2.07 | 5.80K |
| Oct 13, 2026 | 2.04 | 2.05 | 2.03 | 2.04 | 4.70K |
| Oct 12, 2026 | 2.06 | 2.10 | 2.03 | 2.07 | 13.80K |
| Oct 9, 2026 | 2.01 | 2.10 | 2.01 | 2.04 | 6.30K |
| Oct 8, 2026 | 2.21 | 2.21 | 2.01 | 2.02 | 13.40K |
| Oct 7, 2026 | 2.01 | 2.07 | 2.01 | 2.07 | 800 |
| Oct 6, 2026 | 2.12 | 2.12 | 2.02 | 2.05 | 4.40K |
| Oct 5, 2026 | 2.08 | 2.15 | 2.00 | 2.00 | 22.90K |
| Oct 2, 2026 | 2.04 | 2.15 | 2.04 | 2.09 | 21.90K |
| Oct 1, 2026 | 2.05 | 2.06 | 2.02 | 2.04 | 6.70K |
| Sep 30, 2026 | 2.01 | 2.12 | 2.01 | 2.09 | 11.50K |
| Sep 29, 2026 | 2.08 | 2.08 | 2.01 | 2.01 | 4.30K |
| Sep 28, 2026 | 2.02 | 2.04 | 2.01 | 2.02 | 6.90K |
| Sep 25, 2026 | 2.09 | 2.09 | 2.00 | 2.04 | 12.80K |
| Sep 24, 2026 | 2.14 | 2.14 | 2.07 | 2.11 | 5.40K |
| Sep 23, 2026 | 2.13 | 2.20 | 2.06 | 2.06 | 13.90K |
| Sep 22, 2026 | 2.13 | 2.17 | 2.12 | 2.13 | 10.40K |
| Sep 21, 2026 | 2.12 | 2.20 | 2.12 | 2.12 | 17.00K |
About Sera Prognostics
Sera Prognostics (SERA) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in SALT LAKE CITY, UT. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1534969.
SERA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jane F Barlow | Director | Jul 14, 2026 |
| Gregory C Critchfield | Director | Jul 14, 2026 |
| Mark Christopher Capone | Director | Jul 14, 2026 |
| Jeffrey Thomas Elliott | Director | Jun 4, 2026 |
| Kim P. Kamdar | Director | Jul 14, 2026 |
| Sandra Aj Lawrence | Director | Jul 14, 2026 |
| Zhenya Lindgardt | Chief Executive Officer | Sep 11, 2026 |
| Mansoor Raza Mirza | Director | Jul 14, 2026 |
| Joshua Phillips | Director | Jul 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Austin Aerts | Chief Financial Officer | Sep 2, 2026 |
| Dyaarl Lee Jr. Anderson | Chief Commercial Officer | Sep 11, 2026 |
| John J. Boniface | Chief Scientific Officer | May 6, 2026 |
| Scott Gleason | Chief Financial Officer | Sep 1, 2026 |
| Robert Gardner Harrison | Chief Information Officer | May 6, 2026 |
| Tiffany Eul Davis Inglis | Chief Medical Officer | Sep 11, 2026 |
| Benjamin Jackson | General Counsel | Sep 11, 2026 |
| Paul Kearney | Chief Data Officer | May 6, 2026 |
| Zhenya Lindgardt | Chief Executive Officer | Sep 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 10, 2026 | Tiffany Eul Davis Inglis | Sale | 486 | $2.00 |
| Sep 10, 2026 | Tiffany Eul Davis Inglis | Sale | 486 | $2.00 |
| Sep 10, 2026 | Tiffany Eul Davis Inglis | Sale | 486 | $2.00 |
| Sep 10, 2026 | Tiffany Eul Davis Inglis | Sale | 486 | $2.00 |
| Sep 10, 2026 | Zhenya Lindgardt | Sale | 7,022 | $2.00 |
| Sep 10, 2026 | Zhenya Lindgardt | Sale | 7,022 | $2.00 |
| Sep 10, 2026 | Zhenya Lindgardt | Sale | 7,022 | $2.00 |
| Sep 10, 2026 | Zhenya Lindgardt | Sale | 7,022 | $2.00 |
| Sep 10, 2026 | Benjamin Jackson | Sale | 2,190 | $2.00 |
| Sep 10, 2026 | Benjamin Jackson | Sale | 2,190 | $2.00 |
| Sep 10, 2026 | Benjamin Jackson | Sale | 2,190 | $2.00 |
| Sep 10, 2026 | Benjamin Jackson | Sale | 2,190 | $2.00 |
| Sep 10, 2026 | Dyaarl Lee Jr. Anderson | Sale | 1,800 | $2.00 |
| Sep 10, 2026 | Dyaarl Lee Jr. Anderson | Sale | 1,800 | $2.00 |
| Sep 10, 2026 | Dyaarl Lee Jr. Anderson | Sale | 1,800 | $2.00 |
SERA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $81.00K | $-31.93M | -0.67 | $-25.62M |
| Dec 31, 2024 | $77.00K | $-32.90M | -0.99 | $-14.19M |
| Dec 31, 2023 | $306.00K | $-36.24M | -1.16 | $-27.19M |
| Dec 31, 2022 | $268.00K | $-44.19M | -1.43 | $-34.61M |
| Dec 31, 2021 | $82.00K | $-35.01M | -2.33 | $-31.64M |
Latest balance sheet: total assets $86.74M, total liabilities $27.36M, cash $4.40M (as of Jun 30, 2026).
SERA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $2.02 |
| May 6, 2026 | 8-K Item 2.02 (results) | $1.81 |
| Mar 18, 2026 | 8-K Item 2.02 (results) | $1.91 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $2.95 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $2.75 |
| May 7, 2025 | 8-K Item 2.02 (results) | $2.40 |
| Mar 19, 2025 | 8-K Item 2.02 (results) | $4.14 |
| Jan 31, 2025 | 8-K Item 2.02 (results) | $6.47 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $8.74 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 20, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SERA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.